Skip to content
TrialScanner

NCT01238796

A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin

Phase 1CompletedCPIXLead

Registry record

Lead sponsor
Cumberland Pharmaceuticals
Conditions
Kidney Diseases; End Stage Renal Disease
Primary completion
Feb 2011Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01238796 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01238796: A Study to Evaluate the... | TrialScanner